Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2915
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01685918 | Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid Arthritis | ||
| NCT04704154 | A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors | ||
| NCT02232880 | Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation | ||
| NCT00162240 | PPAR - Combination With Metformin | ||
| NCT06923891 | An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients | ||
| NCT04197310 | Cabozantinib and Nivolumab for Carcinoid Tumors | ||
| NCT03377361 | An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread | ||
| NCT01377389 | Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | ||
| NCT02160639 | Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support | ||
| NCT00655746 | The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects | ||
| NCT03422094 | Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma | ||
| NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | ||
| NCT01673854 | Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma | ||
| NCT03599622 | An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease | ||
| NCT04570839 | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. | ||
| NCT00362037 | I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy | ||
| NCT00084253 | Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients | ||
| NCT07091695 | Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab | ||
| NCT00842556 | Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects | ||
| NCT01120457 | First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers | ||
| NCT02492828 | Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden | ||
| NCT06091956 | A Study of Deucravacitinib to Treat LPP and FFA | ||
| NCT03143153 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | ||
| NCT05337137 | A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer | ||
| NCT03058822 | Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial | ||
| NCT00007657 | Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation | ||
| NCT00565773 | Belatacept Post Depletional Repopulation to Facilitate Tolerance | ||
| NCT00508157 | A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome | ||
| NCT00371254 | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer | ||
| NCT05688475 | A Rollover Study of CC-122 | ||
| NCT05524857 | Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP) | ||
| NCT01866930 | Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV | ||
| NCT03824704 | A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) | ||
| NCT00222833 | The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia | ||
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | ||
| NCT06712316 | Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer | ||
| NCT03225716 | A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia | ||
| NCT04895709 | A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors | ||
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | ||
| NCT00429234 | Gemcitabine and Dasatinib in Advanced Solid Tumors | ||
| NCT07636863 | Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig | ||
| NCT01660906 | Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib | ||
| NCT05165264 | A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer | ||
| NCT03331393 | The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis | ||
| NCT01797848 | Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients | ||
| NCT03071133 | Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy | ||
| NCT00734864 | Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma | ||
| NCT04698187 | CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma | ||
| NCT00265967 | Irbesartan in Hypertension | ||
| NCT00343083 | Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442) |
